Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pugh KM"'
Publikováno v:
Journal of Disability Policy Studies; Dec2008, Vol. 19 Issue 3, p182-190, 9p
Autor:
Tiberghien AC; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Vijayakrishnan B; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Esfandiari A; Cancer Research UK, Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom., Ahmed M; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Pardo R; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Bingham J; Cancer Research UK, Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom., Adams L; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Santos K; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Kang GD; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Pugh KM; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom., Afif-Rider S; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Vashisht K; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Haque K; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Tammali R; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Rosfjord E; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Savoca A; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Drug Metabolism and Pharmacokinetics, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Hartley JA; Cancer Research UK, Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom., Howard PW; Tumor Targeted Delivery, Oncology R&D, AstraZeneca, London, United Kingdom.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Feb 01; Vol. 22 (2), pp. 254-263.
Autor:
Füssl F; NIBRT - The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, A94 X099, Ireland., Barry CS; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Pugh KM; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Chooi KP; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Vijayakrishnan B; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Kang GD; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., von Bulow C; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Howard PW; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Bones J; NIBRT - The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, A94 X099, Ireland; School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin, D04 V1W8, Ireland. Electronic address: jonathan.bones@nibrt.ie.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2021 Oct 25; Vol. 205, pp. 114287. Date of Electronic Publication: 2021 Jul 28.
Autor:
Wells CI; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Vasta JD; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Corona CR; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Wilkinson J; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Zimprich CA; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Ingold MR; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Pickett JE; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Drewry DH; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Pugh KM; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Schwinn MK; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Hwang BB; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Zegzouti H; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Huber KVM; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cong M; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Meisenheimer PL; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA., Willson TM; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. tim.willson@unc.edu., Robers MB; Promega Corporation, 2800 Woods Hollow Road, Madison, WI, 53711, USA. matt.robers@promega.com.
Publikováno v:
Nature communications [Nat Commun] 2020 Jun 02; Vol. 11 (1), pp. 2743. Date of Electronic Publication: 2020 Jun 02.
Autor:
D'Ascenzio M; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Pugh KM; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Konietzny R; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Berridge G; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Tallant C; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Hashem S; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK., Monteiro O; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Thomas JR; Novartis Institute for BioMedical Research (NIBR), 180 Massachusetts Ave, Cambridge, MA, 02139, USA., Schirle M; Novartis Institute for BioMedical Research (NIBR), 180 Massachusetts Ave, Cambridge, MA, 02139, USA., Knapp S; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.; Institute for Pharmaceutical Chemistry and Buchmann Institute for Life Sciences, Johann Wolfgang Goethe-University, 60438, Frankfurt am Main, Germany., Marsden B; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK., Fedorov O; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Bountra C; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK., Kessler BM; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK., Brennan PE; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2019 Jan 21; Vol. 58 (4), pp. 1007-1012. Date of Electronic Publication: 2018 Dec 27.
Autor:
Zauri M; Ludwig Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK., Berridge G; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Thézénas ML; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Pugh KM; 1] Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK [2] Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK., Goldin R; Centre for Pathology, Imperial College, London W2 1NY, UK., Kessler BM; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Kriaucionis S; Ludwig Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
Publikováno v:
Nature [Nature] 2015 Aug 06; Vol. 524 (7563), pp. 114-8. Date of Electronic Publication: 2015 Jul 22.
Autor:
Gerten AL; Department of Chemistry, Iowa State University, Ames, Iowa 50011, USA. lstanley@iastate.edu., Slade MC, Pugh KM, Stanley LM
Publikováno v:
Organic & biomolecular chemistry [Org Biomol Chem] 2013 Dec 07; Vol. 11 (45), pp. 7834-7. Date of Electronic Publication: 2013 Oct 17.